Demographics and Outcomes of Initial Phase of COVID-19 Medicines Delivery Units Across 4 UK Centers During Peak B1.1.529 Omicron Epidemic: A Service Evaluation.

Brown, Michael; Saund, Jasjot; Qureshi, Azka; Plowright, Megan; Drury, Katie; Gahir, Joshua; Simpson, Tom; Newman, Thomas; Adams, Kate; Galloway, James; Durairaj, Kezia; Elgizouli, Kamla; Rampling, Tommy; Cole, Joby; Easom, Nicholas; Goodman, Anna L; Marks, Michael

Brown, Michael; Saund, Jasjot; Qureshi, Azka; Plowright, Megan; Drury, Katie; Gahir, Joshua; Simpson, Tom; Newman, Thomas; Adams, Kate; Galloway, James; Durairaj, Kezia; Elgizouli, Kamla; Rampling, Tommy; Cole, Joby; Easom, Nicholas; Goodman, Anna L; Marks, Michael.

Afiliação

Brown M; Division of Infection, University College London Hospitals NHS Foundation Trust, London, United Kingdom.
Saund J; Clinical Research Department, London School of Hygiene and Tropical Medicine, London, United Kingdom.
Qureshi A; Division of Infection, University College London Hospitals NHS Foundation Trust, London, United Kingdom.
Plowright M; Department of Infection, Guys and St Thomas's NHS Foundation Trust, London, United Kingdom.
Drury K; South East London Covid Prevention and Intervention Service, Guys and St Thomas's NHS Foundation Trust, London, United Kingdom.
Gahir J; Department of Infectious Diseases and Tropical Medicine, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, United Kingdom.
Simpson T; Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, United Kingdom.
Newman T; Infection Research Group, Hull University Teaching Hospitals NHS Foundation Trust, Hull, United Kingdom.
Adams K; Division of Infection, University College London Hospitals NHS Foundation Trust, London, United Kingdom.
Galloway J; Department of Respiratory Medicine, Lewisham Hospital, London, United Kingdom.
Durairaj K; Department of Infectious Diseases and Tropical Medicine, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, United Kingdom.
Elgizouli K; Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, United Kingdom.
Rampling T; Infection Research Group, Hull University Teaching Hospitals NHS Foundation Trust, Hull, United Kingdom.
Cole J; Centre for Rheumatic Disease, Kings College London, London, United Kingdom.
Easom N; Department of Infection, Guys and St Thomas's NHS Foundation Trust, London, United Kingdom.
Goodman AL; South East London Covid Prevention and Intervention Service, Guys and St Thomas's NHS Foundation Trust, London, United Kingdom.
Marks M; Infection Research Group, Hull University Teaching Hospitals NHS Foundation Trust, Hull, United Kingdom.

Open Forum Infect Dis ; 9(10): ofac527, 2022 Oct.

Article em En | MEDLINE | ID: mdl-36320201

Palavras-chave

COVID-19; molnupiravir; sotrovimab

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Evaluation_studies Idioma: En Revista: Open Forum Infect Dis Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Reino Unido

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google